Percentage of patients requiring the use of nalaxone or flumazenil for reversal.
Opioid and/or benzodiazepine administration can lead to respiratory depression, brain damage, and even death. Judicious use of opioids for patients that have planned extubation at end of case can avoid use of reversal agents and their side effects. For patients not meeting extubation requirements due to opioids or benzodiazepines, waiting until the effects wear off is preferable to reversal administration.
All patients receiving opioids or benzodiazepines intraoperatively.
Administration of naloxone or flumazenil was not required for the case.
Special Considerations: If naloxone was given as an infusion AND as a bolus, the case is flagged due to the bolus. If naloxone is only given as an infusion, then the case is still evaluated for flumazenil. Patients receiving naloxone as in infusion indicate naloxone is being infused for pruritus for neuraxial technique.
MED 01 is an outcome measure that identifies intraoperative medication overdose by monitoring the administration of opioids and/or benzodiazepines and the administration of reversal agents: flumanzenil and naloxone.
*This measure will include only valid MPOG cases as defined by the Is Valid Case phenotype.
Pending.
Primary Provider - Provider(s) present for longest duration of the case per staff role.
Measure Author |
Instiutution |
Nirav Shah, MD |
University of Michigan |
Jaime Osborne, MSN, RN |
University of Michigan |
Genevieve Bell |
University of Michigan |
Sachin Kheterpal, MD |
University of Michigan |
MPOG Quality Committee |
University of Michigan |
Date Reviewed | Reviewer | Institution | Summary | QC Vote |
---|---|---|---|---|
11/28/2022 |
Karen Domino |
Univeristy of Washington |
Modify |
Date | Criteria | Revision |
---|---|---|
4/8/2024 | All | Measure Retired |